You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘clopidogrel’
October 2011
Br J Cardiol 2011;18:208–210
News from the ESC Congress 2011
Highlights of the European Society of Cardiology (ESC) 2011 Congress, held in Paris, France, from 27th–31st August, included encouraging results with the third new oral
April 2011
Br J Cardiol 2011;18:84−7
Clopidogrel and proton-pump inhibitor interaction: viewpoint and practical clinical approach
The role of clopidogrel after percutaneous coronary intervention (PCI) or acute coronary syndrome (ACS) is well supported by strong clinical evidence, which has led to
February 2011
Br J Cardiol 2011;18:11-3
News from the American Heart Association Scientific Sessions 2010
News from the world of cardiology.
September 2010
Br J Cardiol 2010;17:211-14
News from the 2010 Congress of the European Society of Cardiology
News from the world of cardiology.
September 2010
Br J Cardiol 2010;17:s3-s4
PCI in the UK – the continuing journey
A new and exciting ‘journey’ in interventional cardiology began more than 20 years ago with the introduction of intracoronary stenting.
September 2010
Br J Cardiol 2010;17:s5-s8
Intervention: who to treat and how?
Treatment options in ACS include optimised medical therapy, intervention and surgical revascularisation.
September 2010
Br J Cardiol 2010;17:s9-s14
Optimising medical treatment of ACS
The first widely used antiplatelet agent, aspirin, continues to be standard therapy in ACS patients. The meta-analysis of the Antithrombotic Trialists’ Collaboration showed a 40%
May 2010
Br J Cardiol 2010;17:111-5
News from the 59th Annual Scientific Session of the American College of Cardiology
Neither intensive blood pressure reduction, or adding a fibrate to a statin, appear to be justified in patients with diabetes at high risk of cardiovascular
November 2009
Br J Cardiol 2009;16:269-71
Clopidogrel needed for more than one year after drug-eluting stent placement?
Extending clopidogrel treatment from one to two years after drug-eluting stent placement is associated with a reduction in very late thromboses, new registry data suggest.
November 2009
Br J Cardiol 2009;16:281-6
Pharmaceutical salts: a formulation trick or a clinical conundrum?
The term pharmaceutical salt is used to refer to an ionisable drug that has been combined with a counter-ion to form a neutral complex. Converting